Provider: American Psychological Association
Database: PsycINFO
Content: application/x-research-info-systems
TY - JOUR
DESCRIPTORS - *Central Nervous System; *Drug Therapy; *Drugs; *Dyslexia; *Side
Effects (Drug); Dyscalculia; Learning Disorders
ID - 1977-10962-001
T1 - Encephabol: Our experience with its effect in children with partial
deficiencies--dyslexia, dysorthography and dyscalculia.
JF - Activitas Nervosa Superior
A1 - Vrzal, V.
A1 - Kloboukova, E.
A1 - Reinerova, V.
VL - 17
IS - 4
SP - 302
EP - 302
Y1 - 1975
CY - Czech Republic
PB - CIANS-Homeostasis
SN - 0001-7604(Print)
N2 - Encephabol (100 mg once or twice daily, orally) was administered for periods
ranging from 10 days to 4 yrs to 93 children with dyslexia, dyscalculia, or
dysorthography. The drug proved to have a favorable effect on all the disorders.
The development and maturation of the CNS were facilitated, and somatic symptoms
disappeared. Side effects were few and appeared predominantly in children with
encephalopathic histories. (PsycInfo Database Record (c) 2022 APA, all rights
reserved)
KW - *Central Nervous System
KW - *Drug Therapy
KW - *Drugs
KW - *Dyslexia
KW - *Side Effects (Drug)
KW - Dyscalculia
KW - Learning Disorders
ER -